Cytology and cystoscopy have limited sensitivity and specificity for the diagnosis of urothelial carcinoma ( due to inflammatory atypia, sampling errors, and other clinicopathologic factors that may...more
CAMPBELL, Calif. and CARDIFF, Wales, May 18, 2021 /PRNewswire/ -- KDx Diagnostics, Inc. (KDx), Clinical Innovation Accelerator (CIA), Cardiff University, Cardiff and Vale University Health Board C&VUH
URO17 is a urine test for detecting bladder cancer in people with symptoms associated with malignancy, including blood in the urine (haematuria) or lower urinary tract symptoms. It is also indicated f
KDx Diagnostics, Inc., announced today that it has received Conformité Européene (CE) Marking for its innovative and proprietary urine-based test (the URO17™ test) for bladder cancer...more